MA33516B1 - Nanoparticules métalliques, leur préparation et leurs utilisations - Google Patents
Nanoparticules métalliques, leur préparation et leurs utilisationsInfo
- Publication number
- MA33516B1 MA33516B1 MA34614A MA34614A MA33516B1 MA 33516 B1 MA33516 B1 MA 33516B1 MA 34614 A MA34614 A MA 34614A MA 34614 A MA34614 A MA 34614A MA 33516 B1 MA33516 B1 MA 33516B1
- Authority
- MA
- Morocco
- Prior art keywords
- nanoparticles
- relates
- preparation
- metal nanoparticles
- nanoparticle
- Prior art date
Links
- 239000002082 metal nanoparticle Substances 0.000 title abstract 2
- 239000002105 nanoparticle Substances 0.000 abstract 4
- 230000005865 ionizing radiation Effects 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La présente invention concerne des nanoparticules activables pouvant être utilisées dans le secteur de la santé, en particulier de la santé humaine, pour perturber, modifier ou détruire des cellules, des tissus ou des organes cibles. Elle concerne plus particulièrement des nanoparticules pouvant générer un effet thérapeutique significativement efficace, lorsqu'elles sont exposées à des radiations ionisantes. La nanoparticule de l'invention est une nanoparticule métallique ayant, comme dimension la plus grande, une taille comprise entre environ 80 et 105 nm, le métal ayant de préférence un numéro atomique (Z) d'au moins 25. L'invention concerne également des compositions pharmaceutiques contenant une population de nanoparticules telles que définies précédemment, ainsi que leurs utilisations.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22457609P | 2009-07-10 | 2009-07-10 | |
| EP09165157A EP2275137A1 (fr) | 2009-07-10 | 2009-07-10 | Nanoparticules métalliques, leur préparation et utilisations |
| PCT/EP2010/059871 WO2011003999A1 (fr) | 2009-07-10 | 2010-07-09 | Nanoparticules métalliques, leur préparation et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA33516B1 true MA33516B1 (fr) | 2012-08-01 |
Family
ID=41110399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA34614A MA33516B1 (fr) | 2009-07-10 | 2012-02-08 | Nanoparticules métalliques, leur préparation et leurs utilisations |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US9700621B2 (fr) |
| EP (3) | EP2275137A1 (fr) |
| JP (1) | JP5739883B2 (fr) |
| KR (1) | KR101670757B1 (fr) |
| CN (1) | CN102470173B (fr) |
| AU (1) | AU2010270225B2 (fr) |
| BR (2) | BR122019025997B8 (fr) |
| CA (1) | CA2765290C (fr) |
| CY (1) | CY1118600T1 (fr) |
| DK (2) | DK3178494T3 (fr) |
| EA (1) | EA020942B1 (fr) |
| ES (2) | ES2837412T3 (fr) |
| HR (2) | HRP20170175T1 (fr) |
| HU (2) | HUE031796T2 (fr) |
| IL (1) | IL217287A (fr) |
| LT (1) | LT2451481T (fr) |
| MA (1) | MA33516B1 (fr) |
| MX (2) | MX2012000285A (fr) |
| NZ (1) | NZ597564A (fr) |
| PL (2) | PL3178494T3 (fr) |
| PT (2) | PT2451481T (fr) |
| SG (2) | SG177611A1 (fr) |
| SI (1) | SI2451481T1 (fr) |
| SM (1) | SMT201700123T1 (fr) |
| WO (1) | WO2011003999A1 (fr) |
| ZA (1) | ZA201200902B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012000311B1 (pt) | 2009-07-08 | 2021-12-21 | Clene Nanomedicine, Inc. | Nanocristais com base em ouro para tratamentos médicos e processos eletroquímicos para a fabricação dos mesmos |
| EP2275137A1 (fr) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Nanoparticules métalliques, leur préparation et utilisations |
| US20120190979A1 (en) | 2011-01-24 | 2012-07-26 | Actium BioSystems, LLC | System for automatically amending energy field characteristics in the application of an energy field to a living organism for treatment of invasive agents |
| EP2747838B8 (fr) | 2011-08-26 | 2019-07-17 | Endomagnetics Limited | Appareil de génération de champ énergétique pour traitement du cancer dans des cavités corporelles et des parties de type cavité |
| JP6042450B2 (ja) | 2011-12-16 | 2016-12-14 | ナノビオティックスＮａｎｏｂｉｏｔｉｘ | 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用 |
| PL2948179T3 (pl) | 2013-01-25 | 2019-10-31 | Nanobiotix | Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu |
| MA38687A1 (fr) * | 2013-05-30 | 2017-12-29 | Nanobiotix | Composition pharmaceutique, préparation et utilisations de celle-ci |
| AU2014283217A1 (en) * | 2013-06-20 | 2015-12-24 | Nanobiotix | Compositions and methods for use in medical diagnosis |
| TWI689310B (zh) | 2014-07-11 | 2020-04-01 | 巨生生醫股份有限公司 | 治療鐵缺乏症之方法 |
| JP6778371B2 (ja) * | 2015-01-23 | 2020-11-04 | ミヨシ油脂株式会社 | 金微粒子マトリックスメタロプロテアーゼ阻害剤 |
| JP2018516256A (ja) | 2015-05-28 | 2018-06-21 | ナノビオティックスＮａｎｏｂｉｏｔｉｘ | 治療用ワクチンとしての使用のためのナノ粒子 |
| DE102017101057A1 (de) * | 2017-01-20 | 2018-07-26 | Fraunhofer-Institut für Angewandte Polymerforschung IAP | Zwitterionische Nanopartikel |
| US11116793B2 (en) | 2017-11-13 | 2021-09-14 | National University Corporation Hokkaido University | Modified metal nanoparticle comprising cyclic polyether and pharmaceutical composition |
| CN110883341B (zh) * | 2018-09-11 | 2021-03-30 | 清华大学 | 金纳米团簇制备方法 |
| WO2021060498A1 (fr) * | 2019-09-27 | 2021-04-01 | 国立大学法人京都大学 | Nanoparticules contenant de la silice poreuse, leur procédé de production et composition pharmaceutique pour le traitement par rayonnement |
| EP4157457A1 (fr) * | 2020-05-26 | 2023-04-05 | Nanobiotix | Nanoparticules, rayonnement ionisant et leurs combinaisons thérapeutiques innovantes |
| US12245355B2 (en) | 2021-02-19 | 2025-03-04 | Mevion Medical Systems, Inc. | Gantry for a particle therapy system |
| EP4595983A1 (fr) | 2024-02-05 | 2025-08-06 | BXTA Nanotherapy Limited | Nanoparticules fonctionnalisées avec un agent stabilisant et un agent de ciblage |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006244A2 (fr) * | 1998-07-30 | 2000-02-10 | Hainfeld James F | Particules metalliques de chargement dans des vesicules membranaires cellulaires et particule metallique utilisee pour l'imagerie et la therapie |
| US20070031337A1 (en) * | 2004-06-22 | 2007-02-08 | Reinhard Schulte | Nanoparticle enhanced proton computed tomography and proton therapy |
| DE102007040934A1 (de) | 2007-08-30 | 2009-03-05 | Man Diesel A/S | Verfahren und Vorrichtung zur Reinigung von Abgas |
| EP2130553A1 (fr) * | 2008-06-05 | 2009-12-09 | Nanobiotix | Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo |
| EP2275137A1 (fr) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Nanoparticules métalliques, leur préparation et utilisations |
-
2009
- 2009-07-10 EP EP09165157A patent/EP2275137A1/fr not_active Withdrawn
-
2010
- 2010-07-09 JP JP2012519006A patent/JP5739883B2/ja active Active
- 2010-07-09 CA CA2765290A patent/CA2765290C/fr active Active
- 2010-07-09 SG SG2012002044A patent/SG177611A1/en unknown
- 2010-07-09 KR KR1020127003701A patent/KR101670757B1/ko not_active Expired - Fee Related
- 2010-07-09 ES ES17152585T patent/ES2837412T3/es active Active
- 2010-07-09 SM SM20170123T patent/SMT201700123T1/it unknown
- 2010-07-09 BR BR122019025997A patent/BR122019025997B8/pt not_active IP Right Cessation
- 2010-07-09 PT PT107299174T patent/PT2451481T/pt unknown
- 2010-07-09 EA EA201270154A patent/EA020942B1/ru not_active IP Right Cessation
- 2010-07-09 LT LTEP10729917.4T patent/LT2451481T/lt unknown
- 2010-07-09 HR HRP20170175TT patent/HRP20170175T1/hr unknown
- 2010-07-09 SI SI201031410A patent/SI2451481T1/sl unknown
- 2010-07-09 CN CN201080031148.1A patent/CN102470173B/zh active Active
- 2010-07-09 NZ NZ597564A patent/NZ597564A/xx not_active IP Right Cessation
- 2010-07-09 DK DK17152585.0T patent/DK3178494T3/da active
- 2010-07-09 HU HUE10729917A patent/HUE031796T2/en unknown
- 2010-07-09 EP EP10729917.4A patent/EP2451481B1/fr active Active
- 2010-07-09 SG SG10201403832YA patent/SG10201403832YA/en unknown
- 2010-07-09 ES ES10729917.4T patent/ES2616628T3/es active Active
- 2010-07-09 BR BR112012000530A patent/BR112012000530B8/pt not_active IP Right Cessation
- 2010-07-09 US US13/383,049 patent/US9700621B2/en active Active
- 2010-07-09 MX MX2012000285A patent/MX2012000285A/es active IP Right Grant
- 2010-07-09 MX MX2015010613A patent/MX347606B/es unknown
- 2010-07-09 HU HUE17152585A patent/HUE052686T2/hu unknown
- 2010-07-09 PL PL17152585T patent/PL3178494T3/pl unknown
- 2010-07-09 DK DK10729917.4T patent/DK2451481T3/en active
- 2010-07-09 AU AU2010270225A patent/AU2010270225B2/en not_active Ceased
- 2010-07-09 WO PCT/EP2010/059871 patent/WO2011003999A1/fr not_active Ceased
- 2010-07-09 EP EP17152585.0A patent/EP3178494B1/fr active Active
- 2010-07-09 PT PT171525850T patent/PT3178494T/pt unknown
- 2010-07-09 PL PL10729917T patent/PL2451481T3/pl unknown
-
2011
- 2011-12-29 IL IL217287A patent/IL217287A/en active IP Right Grant
-
2012
- 2012-02-07 ZA ZA2012/00902A patent/ZA201200902B/en unknown
- 2012-02-08 MA MA34614A patent/MA33516B1/fr unknown
-
2017
- 2017-02-07 CY CY20171100166T patent/CY1118600T1/el unknown
- 2017-06-28 US US15/635,252 patent/US10391174B2/en active Active
-
2020
- 2020-12-15 HR HRP20202005TT patent/HRP20202005T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA38318A1 (fr) | Compositions de nanoparticules inorganiques combinées à des rayonnements ionisants pour le traitement du cancer | |
| Rodrigues et al. | Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics | |
| Bodaghi-Namileh et al. | Acetyl-l-carnitine attenuates arsenic-induced liver injury by abrogation of mitochondrial dysfunction, inflammation, and apoptosis in rats | |
| Munawer et al. | Biofabrication of gold nanoparticles mediated by the endophytic Cladosporium species: Photodegradation, in vitro anticancer activity and in vivo antitumor studies | |
| MA32453B1 (fr) | Manoparticules inograniques, leur preparation et leurs utilisations | |
| Sharma et al. | Antibacterial activity of colloidal copper nanoparticles against Gram‐negative (Escherichia coli and Proteus vulgaris) bacteria | |
| Zhang et al. | Antibiofilm activity of ultra-small gold nanoclusters against Fusobacterium nucleatum in dental plaque biofilms | |
| Girma et al. | Green-synthesised silver nanoparticles: antibacterial activity and alternative mechanisms of action to combat multidrug-resistant bacterial pathogens: a systematic literature review | |
| Jerobin et al. | Antibacterial activity of neem nanoemulsion and its toxicity assessment on human lymphocytes in vitro | |
| EA201270154A1 (ru) | Металлические наночастицы, их получение и применение | |
| Castillo-Martínez et al. | Antibacterial and antibiofilm activities of the photothermal therapy using gold nanorods against seven different bacterial strains | |
| Vega-Jiménez et al. | Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications | |
| Sun et al. | Synergy between polyvinylpyrrolidone-coated silver nanoparticles and azole antifungal against drug-resistant Candida albicans | |
| Ribeiro et al. | Ceria nanoparticles decrease UVA-induced fibroblast death through cell redox regulation leading to cell survival, migration and proliferation | |
| Ritwik et al. | Peripheral odontogenic fibroma: a clinicopathologic study of 151 cases and review of the literature with special emphasis on recurrence | |
| NZ703047A (en) | Methods of enhancing drug delivery and effectiveness of therapeutic agents | |
| Metwally et al. | Silver nanoparticles biosynthesized with salvia officinalis leaf exert protective effect on hepatic tissue injury induced by Plasmodium chabaudi | |
| Guo et al. | Polydopamine dual-modal nanotherapy synergizes photothermal antibacterial and nanozyme anti-inflammatory effects for periodontitis treatment | |
| Zafar et al. | Copper (II) oxide nanoparticles augment antifilarial activity of Albendazole: In vitro synergistic apoptotic impact against filarial parasite Setaria cervi | |
| Xiao et al. | Tungsten disulfide atomic crystals with RONS scavenging and liver targeting capabilities for acetaminophen-induced acute liver injury therapy | |
| Ahamed et al. | Natural antioxidant curcumin attenuates NiO nanoparticle-induced cytotoxicity in mouse spermatogonia cells: A mechanistic study | |
| Ekrikaya et al. | Evaluation of the antibacterial activity, surface microhardness, and color change of glass ionomer cement containing green synthesized Ag@ MoS2 nanocomposite after thermal aging | |
| Miran et al. | Biosynthesized selenium nanoparticles enhance antibiofilm properties of PMMA resin for dental applications | |
| Hinaz | Green synthesis and antimicrobial activity of titanium dioxide nanoparticles with neem and tulsi extract against oral pathogens | |
| Xia et al. | Rhamnolipid/Fullerene Nanocomposites as Potent Radical Scavengers for Acute Severe Ulcerative Colitis Prevention: A Low-Dose Therapeutic Approach |